Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
NIH-funded research sheds light on link between COVID-19 and increased risk of cardiovascular disease and stroke.
When given a choice, most women chose injectable cabotegravir over daily prevention pills.
Hepatitis C prevalence was higher among people with unstable housing and those who injected drugs every day.
NAFLD is associated with risk factors such as obesity and inflammatory biomarkers and with events including heart attacks and strokes.
New deep brain stimulation device coupled with powerful AI may improve therapy for treatment-resistant depression.
Only 20% of people covered by Medicaid received treatment within six months of their HCV diagnosis.
With Campbell Foundation funding, a Wistar Institute scientist studies ways to engineer immune cells to attack HIV-infected cells.
The vaccine, dubbed VIR-1388, is designed to stimulate the production of T cells to fight HIV.
Study findings identify a potential marker that could help identify people at high risk of developing long COVID.
People with repeat monkeypox infections and those who were vaccinated are less likely to develop severe symptoms.
Certain drugs in this class may increase the likelihood of diabetes and hypertension, but cardiovascular risk factors can be managed.
Studies highlight the need for better prevention and management of age-related health problems.
Research on the links between tenofovir and other antiretrovirals, SARS-CoV-2 infection and COVID severity has produced mixed results.
U.S. syphilis incidence has increased since 2000, with an escalating toll in medically underserved populations.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.